Feedback

An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease

Affiliation
Center for Endocrine Metabolic and Immune Diseases ,Beijing Luhe Hospital ,Capital Medical University ,Beijing ,China
Feng, Anqi;
Affiliation
Center for Endocrine Metabolic and Immune Diseases ,Beijing Luhe Hospital ,Capital Medical University ,Beijing ,China
Yin, Ruili;
Affiliation
Center for Endocrine Metabolic and Immune Diseases ,Beijing Luhe Hospital ,Capital Medical University ,Beijing ,China
Xu, Rong;
Affiliation
Center for Endocrine Metabolic and Immune Diseases ,Beijing Luhe Hospital ,Capital Medical University ,Beijing ,China
Zhang, Baoyu;
Affiliation
Center for Endocrine Metabolic and Immune Diseases ,Beijing Luhe Hospital ,Capital Medical University ,Beijing ,China
Yang, Longyan

Diabetic kidney disease (DKD) is a severe microvascular complication of diabetes, which can result in end-stage renal disease (ESRD). As the main site of renal reabsorption and its exposed environment, renal tubules can be damaged by various factors. Recent studies have shown that renal tubular epithelial cells (RTECs) injury plays an important role in the occurrence and progression of DKD. The glycolipid metabolism disorders are a vital factor contributing to RTECs injury, which in turn affects the progression of DKD. Abnormal glucose and lipid metabolism can cause oxidative stress, mitochondrial damage, cell apoptosis and lipid accumulation, which can cause RTECs injury. Therefore, this review describes the main pathological mechanism of the injury caused by glycolipid metabolism and the corresponding therapeutic drugs in the clinical treatment of DKD.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Feng, Yin, Xu, Zhang and Yang.

Use and reproduction: